X4 PHARMACEUTICALS

Serial Number 88516686
Registration 6521317
700

Registration Progress

Application Filed
Jul 16, 2019
Under Examination
Jan 21, 2020
Approved for Publication
Nov 26, 2019
Published for Opposition
Nov 26, 2019
Registered
Oct 12, 2021

Trademark Image

X4 PHARMACEUTICALS

Basic Information

Serial Number
88516686
Registration Number
6521317
Filing Date
July 16, 2019
Registration Date
October 12, 2021
Published for Opposition
November 26, 2019
Drawing Code
3000

Status Summary

Current Status
Active
Status Code
700
Status Date
Oct 12, 2021
Registration
Registered
Classes
005 042

Rights Holder

X4 Pharmaceuticals, Inc.

03
Address
955 Massachusetts Avenue, 4th Floor
Cambridge, MA 02139

Ownership History

X4 Pharmaceuticals, Inc.

Original Applicant
03
Cambridge, MA

X4 Pharmaceuticals, Inc.

Owner at Publication
03
Cambridge, MA

X4 Pharmaceuticals, Inc.

Original Registrant
03
Cambridge, MA

Legal Representation

Attorney
Glenn A. Gundersen

USPTO Deadlines

Next Deadline
800 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2021-10-12)
Due Date
October 12, 2027
Grace Period Ends
April 12, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

42 events
Date Code Type Description Documents
Oct 12, 2021 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Sep 8, 2021 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Sep 7, 2021 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Aug 20, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 19, 2021 EX4G S SOU EXTENSION 4 GRANTED Loading...
Aug 19, 2021 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Aug 11, 2021 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Aug 10, 2021 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Aug 10, 2021 INCE O ITU OFFICE ACTION ISSUED FOR EXTENSION REQUEST Loading...
Aug 4, 2021 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Aug 4, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 4, 2021 EXT4 S SOU EXTENSION 4 FILED Loading...
Aug 4, 2021 IUAF S USE AMENDMENT FILED Loading...
Jul 22, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 20, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 20, 2021 EXT3 S SOU EXTENSION 3 FILED Loading...
Jul 20, 2021 EX3G S SOU EXTENSION 3 GRANTED Loading...
Jan 23, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 21, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 21, 2021 EXT2 S SOU EXTENSION 2 FILED Loading...
Jan 21, 2021 EX2G S SOU EXTENSION 2 GRANTED Loading...
Jul 22, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 20, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 20, 2020 EXT1 S SOU EXTENSION 1 FILED Loading...
Jul 20, 2020 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jan 21, 2020 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Nov 26, 2019 PUBO A PUBLISHED FOR OPPOSITION Loading...
Nov 26, 2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Nov 6, 2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Oct 23, 2019 ALIE A ASSIGNED TO LIE Loading...
Oct 16, 2019 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Oct 11, 2019 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Oct 11, 2019 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Oct 11, 2019 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Oct 11, 2019 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Oct 10, 2019 CNRT R NON-FINAL ACTION WRITTEN Loading...
Oct 10, 2019 GNRT F NON-FINAL ACTION E-MAILED Loading...
Oct 10, 2019 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Oct 2, 2019 DOCK D ASSIGNED TO EXAMINER Loading...
Jul 23, 2019 MDSM E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Jul 22, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jul 19, 2019 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of cancers, rare diseases, primary immune disorders and other diseases
First Use Anywhere: Jun 23, 2020
First Use in Commerce: Jun 23, 2020
Class 042
Research and development in the pharmaceutical field; scientific research; scientific investigations for medical purposes
First Use Anywhere: Jun 11, 2019
First Use in Commerce: Jun 11, 2019

Additional Information

Design Mark
The mark consists of the letter "X" to the left of the numeral "4" and directly above the word "PHARMACEUTICALS", with a solid sphere above the vertical bar in the numeral "4".
Color Claim
Color is not claimed as a feature of the mark.
Pseudo Mark
XFOUR PHARMACEUTICALS

Classification

International Classes
005 042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"PHARMACEUTICALS"